NAOV (nanovibronix.com) חוב כולל להון

NanoVibronix, Inc. (NAOV) ensures a stable cash flow that fully covers current operating expenses. Business growth is driven by the expansion of PainShield and UroShield systems across US clinics, as well as new insurance codes. The price trend on GURU.Markets shows that the total debt-to-equity ratio is 0.03. The company develops unique non-invasive ultrasound devices for combating infections, which allows it to maintain significant pricing power.

This ratio determines the proportion of borrowed funds within the asset structure relative to equity, measuring the company's degree of dependence on external financing. By analyzing the financial leverage of the total debt-to-equity ratio, an investor assesses the ability of NanoVibronix, Inc. (NAOV) to scale the production of ultrasonic patches without incurring a critical debt load, which is essential for maintaining the pace of innovative development.